Literature DB >> 25254032

The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Grazia Maria Virzì1, Anna Clementi2, Alessandra Brocca3, Massimo de Cal3, Giorgio Vescovo4, Antonio Granata5, Claudio Ronco3.   

Abstract

The organ crosstalk can be defined as the complex biological communication and feedback between distant organs mediated via cellular, molecular, neural, endocrine and paracrine factors. In the normal state, this crosstalk helps to maintain homeostasis and optimal functioning of the human body. However, during disease states this very crosstalk can carry over the influence of the diseased organ to initiate and perpetuate structural and functional dysfunction in the other organs. Heart performance and kidney function are intimately interconnected, and the communication between these organs occurs through a variety of bidirectional pathways. The cardiorenal syndrome (CRS) is defined as a complex pathophysiological disorder of the heart and the kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other organ. In particular, CRS type 1 is characterized by a rapid worsening of the cardiac function leading to acute kidney injury. This clinical condition requires a more complex management given its more complicated hospital course and higher mortality. A lot of research has emerged in the last years trying to explain the pathophysiology of CRS type 1 which remains in part poorly understood. This review primarily focuses on the hemodynamic and nonhemodynamic mechanisms involved in this syndrome.

Entities:  

Keywords:  Acute kidney injury; Cardiorenal syndrome; Heart and renal dysfunction; Hemodynamic mechanisms; Organ crosstalk

Year:  2014        PMID: 25254032      PMCID: PMC4164059          DOI: 10.1159/000362650

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  69 in total

Review 1.  Pathophysiology of contrast-induced nephropathy.

Authors:  James Tumlin; Fulvio Stacul; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Peter A McCullough
Journal:  Am J Cardiol       Date:  2006-02-17       Impact factor: 2.778

Review 2.  Distant-organ changes after acute kidney injury.

Authors:  Carolyn M Feltes; Jennifer Van Eyk; Hamid Rabb
Journal:  Nephron Physiol       Date:  2008-09-18

Review 3.  The immunological axis in heart failure: importance of the leukocyte differential.

Authors:  Muthiah Vaduganathan; Stephen J Greene; Javed Butler; Hani N Sabbah; Eduard Shantsila; Gregory Y H Lip; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

4.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

Review 5.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

6.  Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.

Authors:  M Packer; W H Lee; P D Kessler
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

Review 7.  Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.

Authors:  Nadia Aspromonte; Dinna N Cruz; Roberto Valle; Monica Bonello; Marco Tubaro; Giovanni Gambaro; Giuseppe Marchese; Massimo Santini; Claudio Ronco
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-05-21       Impact factor: 4.481

8.  [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms].

Authors:  Grazia Maria Virzi'; Massimo de Cal; Dinna N Cruz; Chiara Bolin; Giorgio Vescovo; Claudio Ronco
Journal:  G Ital Nefrol       Date:  2012 Nov-Dec

9.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

Review 10.  Stress oxidative: nephrolithiasis and chronic kidney diseases.

Authors:  S R Khan
Journal:  Minerva Med       Date:  2013-02       Impact factor: 4.806

View more
  14 in total

1.  Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1.

Authors:  Andrea Breglia; Grazia Maria Virzì; Silvia Pastori; Alessandra Brocca; Massimo de Cal; Chiara Bolin; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2018-05-30       Impact factor: 2.041

2.  Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.

Authors:  Silvia Pastori; Grazia Maria Virzì; Alessandra Brocca; Massimo de Cal; Anna Clementi; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-02-11       Impact factor: 2.041

Review 3.  Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome.

Authors:  Yoshitsugu Obi; Taehee Kim; Csaba P Kovesdy; Alpesh N Amin; Kamyar Kalantar-Zadeh
Journal:  Cardiorenal Med       Date:  2015-11-06       Impact factor: 2.041

4.  Effects of recombinant human brain natriuretic peptide on renal function in patients with acute heart failure following myocardial infarction.

Authors:  Yanbo Wang; Xinshun Gu; Weize Fan; Yanming Fan; Wei Li; Xianghua Fu
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

5.  Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways.

Authors:  Silvia Pastori; Grazia Maria Virzì; Alessandra Brocca; Massimo de Cal; Vincenzo Cantaluppi; Chiara Castellani; Marny Fedrigo; Gaetano Thiene; Maria Luisa Valente; Annalisa Angelini; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-09-02       Impact factor: 2.041

Review 6.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

7.  Incidence, Mortality and Positive Predictive Value of Type 1 Cardiorenal Syndrome in Acute Coronary Syndrome.

Authors:  Raquel Pimienta González; Patricia Couto Comba; Marcos Rodríguez Esteban; José Juan Alemán Sánchez; Julio Hernández Afonso; María Del Cristo Rodríguez Pérez; Itahisa Marcelino Rodríguez; Buenaventura Brito Díaz; Roberto Elosua; Antonio Cabrera de León
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

8.  Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients.

Authors:  Chia-Ter Chao; Hung-Bin Tsai; Chia-Yi Wu; Yu-Feng Lin; Nin-Chieh Hsu; Jin-Shin Chen; Kuan-Yu Hung
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

9.  When CRRT on ECMO Is Not Enough for Potassium Clearance: A Case Report.

Authors:  Janice A Tijssen; Guido Filler
Journal:  Can J Kidney Health Dis       Date:  2017-08-21

10.  Combination of Amino-Terminal Pro- BNP , Estimated GFR , and High-Sensitivity CRP for Predicting Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients.

Authors:  De-Qiang Zhang; Hong-Wei Li; Hai-Ping Chen; Qing Ma; Hui Chen; Yun-Li Xing; Xue-Qiao Zhao
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.